breast cancer

BioMarin Gains on Prospects for Experimental Cancer Drug
Bloomberg
Thu, 05/23/13 - 11:49 am
Biomarin
Ewing's sarcoma
BMN-673
breast cancer
ovarian cancer
small cell lung cancer
Merrimack completes enrollement in a Phase 2 study of MM-121 with Sanofi
The Fly on the Wall
Thu, 05/23/13 - 09:44 am
Merrimack Pharmaceuticals
MM-121
breast cancer
Puma Biotech Gains After Rival Drug Data Show No Threat
Bloomberg
Sat, 05/18/13 - 11:43 am
Puma Biotechnology
neratinib
breast cancer
cancer
Netupitant Results Could Roil Tesaro In May
Seeking Alpha
Mon, 05/6/13 - 10:48 am
Tesaro
Netupitant
breast cancer
ovarian cancer
niraparib
Sanofi
Roche
OPKO Health
Merck
GSK
Eisai
3 Biotechs Targeting Breast Cancer
Seeking Alpha
Thu, 04/18/13 - 06:59 pm
breast cancer
Pfizer
Celldex
Galena Biopharma
Supreme Court To Hear Case That May Reshape Biopharma Research
Pharmalot
Mon, 04/15/13 - 09:33 am
Supreme Court
Myriad Genetics
breast cancer
ovarian cancer
gene patents
Pfizer's New Breast Cancer Drug Could Be A Game Changer
Seeking Alpha
Mon, 04/15/13 - 08:40 am
Pfizer
breast cancer
palbociclib
AstraZeneca
Novartis
GSK
Bristol-Myers Squibb
Pfizer’s Big Breakthrough for Breast Cancer
Wall Street Cheat Street
Sun, 04/14/13 - 12:19 pm
Pfizer
palbociclib
breast cancer
Biotech Industry at Stake in Human Gene Patent Decision
Bloomberg
Fri, 04/12/13 - 09:59 am
biotech
human gene patents
Supreme Court
Myriad Genetics
breast cancer
ovarian cancer
FDA designates experimental Pfizer drug for common breast cancer type a breakthrough therapy
Yahoo/AP
Thu, 04/11/13 - 11:28 am
FDA
Pfizer
breast cancer
palbociclib
Pfizer’s Palbociclib (PD-0332991) Receives FDA Breakthrough Therapy Designation For Potential Treatment Of Patients With Breast Cancer
Yahoo
Wed, 04/10/13 - 11:10 am
Pfizer
palbociclib
FDA
breast cancer
Pfizer's Next Big Deal Will Generate Income For Novartis, Prevent Competitors' Initiative
Seeking Alpha
Fri, 03/29/13 - 10:54 am
Pfizer
Novartis
breast cancer
palbociclib
U.K. Regulators Sour on Novartis Breast Cancer Drug Afinitor
Motley Fool
Sat, 03/23/13 - 09:48 am
Novartis
Afinitor
breast cancer
Navidea drops after FDA nod for drug used in cancer patients
Fierce Biotech
Thu, 03/14/13 - 11:39 am
Navidea Biopharmaceuticals
FDA
breast cancer
Lymphoseek
Tackling Cancer: Breast Cancer's Biggest Current & Upcoming Players
Motley Fool
Tue, 03/12/13 - 05:36 pm
breast cancer
aromatase inhibitors
AstraZeneca
Novartis
Femara
Arimidex
SERMs
Nolvadex
Roche
Herceptin
GSK
Tykerb
Xeloda
Perjeta
Kadcyla
Immunogen
Lymphoseek
Navidea Biopharmaceuticals
Nexavar
ONYX Pharmaceuticals
After FDA Approval, A New And Bigger Catalyst Looms Closer For Immunogen
Seeking Alpha
Mon, 03/11/13 - 11:09 am
Immunogen
trastuzumab
breast cancer
Ziopharm initiates Phase 2 study of Ad-RTLS IL-12
Yahoo/Fly on the Wall
Mon, 03/11/13 - 11:07 am
Ziopharm
Ad-RTS IL-12
breast cancer
Agilent's Assays Get Kadcyla Stamp
Yahoo/Zacks
Thu, 03/7/13 - 11:26 am
Agilent
Kadcyla
breast cancer
Genentech
assays
FDA OKs Roche drug for late-stage metastatic breast cancer
Reuters
Fri, 02/22/13 - 11:01 am
Roche
metastatic breast cancer
breast cancer
Kadcyla
Anything Can Happen This Year For Celldex
Seeking Alpha
Mon, 02/18/13 - 12:18 pm
Celldex
breast cancer
CDX-110
CDX-111
Seattle Genetics

Pages